SGLT2 Inhibitors Market Size, Share & Trends Analysis Report By Drug (Canagliflozin, Dapagliflozin, Empagliflozin, Ertugliflozin, Ipragliflozin, Sotagliflozin, Others), By Indication (Type 2 Diabetes, Cardiovascular, Chronic Kidney Disease, Weight Management, Others), By Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: August 24, 2026 | Author: Tejas Zamde | Format:

Table Of Content

  1. Executive Summary

  2. Research Scope & Segmentation
    1. Research Objectives
    2. Limitations & Assumptions
    3. Market Scope & Segmentation
    4. Currency & Pricing Considered
  3. Market Opportunity Assessment
    1. Emerging Regions / Countries
    2. Emerging Companies
    3. Emerging Applications / End Use
  4. Market Trends
    1. Drivers
    2. Market Warning Factors
    3. Macro Economic Indicators
    4. Geopolitical Impact
    5. Technology Factors
  5. Market Assessment
    1. Porters Five Forces Analysis
    2. Value Chain Analysis
  6. SGLT2 Inhibitors Market Size Analysis
    1. Introduction
    2. SGLT2 Inhibitors Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Canagliflozin
      2. Dapagliflozin
      3. Empagliflozin
      4. Ertugliflozin
      5. Ipragliflozin
      6. Sotagliflozin
      7. Others
    3. SGLT2 Inhibitors Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Type 2 Diabetes
      2. Cardiovascular
      3. Chronic Kidney Disease 
      4. Weight Management
      5. Others
    4. SGLT2 Inhibitors Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
  7. North America SGLT2 Inhibitors Market Size Analysis
    1. Introduction
    2. SGLT2 Inhibitors Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Canagliflozin
      2. Dapagliflozin
      3. Empagliflozin
      4. Ertugliflozin
      5. Ipragliflozin
      6. Sotagliflozin
      7. Others
    3. SGLT2 Inhibitors Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Type 2 Diabetes
      2. Cardiovascular
      3. Chronic Kidney Disease 
      4. Weight Management
      5. Others
    4. SGLT2 Inhibitors Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. U.S.
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Canada
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  8. Europe SGLT2 Inhibitors Market Size Analysis
    1. Introduction
    2. SGLT2 Inhibitors Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Canagliflozin
      2. Dapagliflozin
      3. Empagliflozin
      4. Ertugliflozin
      5. Ipragliflozin
      6. Sotagliflozin
      7. Others
    3. SGLT2 Inhibitors Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Type 2 Diabetes
      2. Cardiovascular
      3. Chronic Kidney Disease 
      4. Weight Management
      5. Others
    4. SGLT2 Inhibitors Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. U.K.
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Germany
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. France
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. Spain
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Italy
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Russia
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. Nordic
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    12. Benelux
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    13. Rest of Europe
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  9. APAC SGLT2 Inhibitors Market Size Analysis
    1. Introduction
    2. SGLT2 Inhibitors Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Canagliflozin
      2. Dapagliflozin
      3. Empagliflozin
      4. Ertugliflozin
      5. Ipragliflozin
      6. Sotagliflozin
      7. Others
    3. SGLT2 Inhibitors Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Type 2 Diabetes
      2. Cardiovascular
      3. Chronic Kidney Disease 
      4. Weight Management
      5. Others
    4. SGLT2 Inhibitors Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. China
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Korea
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Japan
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. India
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Australia
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Taiwan
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. South East Asia
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    12. Rest of Asia-Pacific
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  10. Middle East and Africa SGLT2 Inhibitors Market Size Analysis
    1. Introduction
    2. SGLT2 Inhibitors Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Canagliflozin
      2. Dapagliflozin
      3. Empagliflozin
      4. Ertugliflozin
      5. Ipragliflozin
      6. Sotagliflozin
      7. Others
    3. SGLT2 Inhibitors Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Type 2 Diabetes
      2. Cardiovascular
      3. Chronic Kidney Disease 
      4. Weight Management
      5. Others
    4. SGLT2 Inhibitors Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. UAE
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Turkey
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Saudi Arabia
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. South Africa
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Egypt
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Nigeria
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    11. Rest of MEA
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  11. LATAM SGLT2 Inhibitors Market Size Analysis
    1. Introduction
    2. SGLT2 Inhibitors Market Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
      1. Canagliflozin
      2. Dapagliflozin
      3. Empagliflozin
      4. Ertugliflozin
      5. Ipragliflozin
      6. Sotagliflozin
      7. Others
    3. SGLT2 Inhibitors Market Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
      1. Type 2 Diabetes
      2. Cardiovascular
      3. Chronic Kidney Disease 
      4. Weight Management
      5. Others
    4. SGLT2 Inhibitors Market Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
      1. Hospital Pharmacies
      2. Drug Stores & Retail Pharmacies
      3. Online Pharmacies
    5. Brazil
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    6. Mexico
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    7. Argentina
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    8. Chile
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    9. Colombia
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
    10. Rest of LATAM
      1. Introduction
      2. Market Size & Forecast By Drug 2022-2034 (USD MILLION/ Units)
        1. Canagliflozin
        2. Dapagliflozin
        3. Empagliflozin
        4. Ertugliflozin
        5. Ipragliflozin
        6. Sotagliflozin
        7. Others
      3. Market Size & Forecast By Indication 2022-2034 (USD MILLION/ Units)
        1. Type 2 Diabetes
        2. Cardiovascular
        3. Chronic Kidney Disease 
        4. Weight Management
        5. Others
      4. Market Size & Forecast By Distribution Channel 2022-2034 (USD MILLION/ Units)
        1. Hospital Pharmacies
        2. Drug Stores & Retail Pharmacies
        3. Online Pharmacies
  12. Competitive Landscape
    1. SGLT2 Inhibitors Market Share By Players
    2. M&A Agreements & Collaboration Analysis
    3. Tier Structure Analysis
    4. Recent Developments
  13. Market Players Assessment
    1. Arena Pharmaceuticals
      1. Overview
      2. Business Information
      3. Revenue
      4. ASP
      5. SWOT Analysis
      6. Recent Developments
    2. Astellas Pharma
    3. AstraZeneca
    4. Boehringer Ingelheim
    5. Chong Kun Dang
    6. Cipla Ltd.
    7. Dr Reddy's Laboratories
    8. Eli Lilly and Company
    9. Glenmark Pharma
    10. Janssen Pharmaceuticals
    11. Lupin Ltd.
    12. Merck & Co. Inc.
    13. Otsuka Pharmaceutical
    14. Sumitomo Pharma
    15. Sun Pharmaceutical Ltd.
    16. Taisho Pharma
    17. Torrent Pharma
    18. Zydus Lifesciences
    19. Others
  14. Research Methodology
    1. Research Data
      1. Secondary Data
        1. Major Secondary Sources
        2. Key Data from Secondary Sources
      2. Primary Data
        1. Key Data from Primary Sources
        2. Breakdown of Primaries
      3. Secondary And Primary Research
        1. Key Industry Insights
    2. Market Size Estimation
      1. Bottom-Up Approach
      2. Top-Down Approach
      3. Market Projection
    3. Research Assumptions
      1. Assumptions
    4. Limitations
    5. Risk Assessment
  15. Appendix
    1. Discussion Guide
    2. Customization Options
    3. Related Reports

  16. Disclaimer

List of Tables

Table 1: Global SGLT2 Inhibitors Market Size and Forecast By Regions - 2022-2034 (USD Billion)

Table 2: Global SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 3: Global SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 4: Global SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 5: North America SGLT2 Inhibitors Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 6: North America SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 7: North America SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 8: North America SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 9: U.S. SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 10: U.S. SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 11: U.S. SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 12: Canada SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 13: Canada SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 14: Canada SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 15: Europe SGLT2 Inhibitors Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 16: Europe SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 17: Europe SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 18: Europe SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 19: U.K. SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 20: U.K. SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 21: U.K. SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 22: Germany SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 23: Germany SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 24: Germany SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 25: France SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 26: France SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 27: France SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 28: Spain SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 29: Spain SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 30: Spain SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 31: Italy SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 32: Italy SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 33: Italy SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 34: Russia SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 35: Russia SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 36: Russia SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 37: Nordic SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 38: Nordic SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 39: Nordic SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 40: Benelux SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 41: Benelux SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 42: Benelux SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 43: Rest of Europe SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 44: Rest of Europe SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 45: Rest of Europe SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 46: APAC SGLT2 Inhibitors Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 47: APAC SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 48: APAC SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 49: APAC SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 50: China SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 51: China SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 52: China SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 53: Korea SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 54: Korea SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 55: Korea SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 56: Japan SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 57: Japan SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 58: Japan SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 59: India SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 60: India SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 61: India SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 62: Australia SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 63: Australia SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 64: Australia SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 65: Taiwan SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 66: Taiwan SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 67: Taiwan SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 68: South East Asia SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 69: South East Asia SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 70: South East Asia SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 71: Rest of Asia-Pacific SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 72: Rest of Asia-Pacific SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 73: Rest of Asia-Pacific SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 74: Middle East and Africa SGLT2 Inhibitors Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 75: Middle East and Africa SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 76: Middle East and Africa SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 77: Middle East and Africa SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 78: UAE SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 79: UAE SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 80: UAE SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 81: Turkey SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 82: Turkey SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 83: Turkey SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 84: Saudi Arabia SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 85: Saudi Arabia SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 86: Saudi Arabia SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 87: South Africa SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 88: South Africa SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 89: South Africa SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 90: Egypt SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 91: Egypt SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 92: Egypt SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 93: Nigeria SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 94: Nigeria SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 95: Nigeria SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 96: Rest of MEA SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 97: Rest of MEA SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 98: Rest of MEA SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 99: LATAM SGLT2 Inhibitors Market Size and Forecast By Country - 2022-2034 (USD Billion)

Table 100: LATAM SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 101: LATAM SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 102: LATAM SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 103: Brazil SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 104: Brazil SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 105: Brazil SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 106: Mexico SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 107: Mexico SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 108: Mexico SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 109: Argentina SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 110: Argentina SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 111: Argentina SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 112: Chile SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 113: Chile SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 114: Chile SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 115: Colombia SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 116: Colombia SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 117: Colombia SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

Table 118: Rest of LATAM SGLT2 Inhibitors Market Size and Forecast By Drug - 2022-2034 (USD Billion)

Table 119: Rest of LATAM SGLT2 Inhibitors Market Size and Forecast By Indication - 2022-2034 (USD Billion)

Table 120: Rest of LATAM SGLT2 Inhibitors Market Size and Forecast By Distribution Channel - 2022-2034 (USD Billion)

We are featured on: